<DOC>
	<DOCNO>NCT00895401</DOCNO>
	<brief_summary>This Phase IV randomize control study assess effectiveness commercially available nutritional supplement malnourish prevalent hemodialysis patient . Patients randomize either receive one Nepro Carb Steady dialysis treatment 6 month receive standard care counsel malnutrition . The primary hypothesis hypoalbuminemic maintenance hemodialysis patient demonstrate improvement albumin level oral nutritional supplement provide in-center thrice weekly addition standard care compare malnourish maintenance hemodialysis patient provide standard care alone .</brief_summary>
	<brief_title>DaVita Assessment Nutritional Supplement Effects ( DANSE )</brief_title>
	<detailed_description />
	<mesh_term>Malnutrition</mesh_term>
	<criteria>Patient least 18 year age Patient hemodialysis &gt; 6 month time study entry Patient dialyze three time week Patient agree try ONS 6 month study period . Patient demonstrate albumin &lt; 3.5 g/dL last available lab drawn dialysis facility Patient adequately dialyze Kt/V &gt; 1.4 recent lab draw Patient capable reading comprehend Informed Consent Form provide write informed consent Peritoneal dialysis Dysphagia Aspiration risk Difficulty swallow History symptomatic intolerance food liquid consumption dialysis treatment Terminal illnesses life expectancy &lt; 6 month , e.g . stage IV cancer full blow AIDS Concurrent appetite stimulant Use IDPN last 3 month Inability follow comply instruction guideline Severe liver disease define recent SGOT &gt; 78 Active malignancy ( skin ) Major surgery within previous 6 month anticipate 90day study period Females pregnant breastfeeding Considered clinically unstable treat nephrologists Noncompliance dialysis treatment ( Missed &gt; 2 treatment prior month due noncompliance ) Extended frequent hospitalization define hospitalization longer 15 day discharge within last 30 day great 3 admission within last 30 day Regular supplement use define consumption &gt; 7 serving commercially available kcal/ protein supplement prior month Any clinically significant medical disease condition , investigator 's opinion , may interfere protocol adherence patient 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Nutritional supplement</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Nepro Carb Steady</keyword>
</DOC>